Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 2/25/2013 10:44:20 AM : Outperform Start Price: $9.65 CLDX Score: +7.02

great pipeline

Featured Broker Partners


Advertisement